Results 111 to 120 of about 2,179 (173)

The Current State of the Art in PAMAM and PLL Dendrimers, Boron Clusters, and Their Complexes for Biomedical Use. [PDF]

Biomedicines
Kołodziejczyk AM, Błaszczyk E, Karwowski BT.   +2 more
europepmc   +1 more source

Enhancement of dose distribution using tissue compensators in boron neutron capture therapy. [PDF]

J Appl Clin Med Phys
Sasaki A, Hu N, Nojiri M, Akita K, Yoshikawa S, Kohigashi Y, Nihei K, Aihara T, Takeno S, Yoshino Y, Tanaka H, Ono K.   +11 more
europepmc   +1 more source

18F-BPA as a surrogate tracer for BPA in BNCT: comparative analysis of transport mechanisms and biodistribution. [PDF]

J Radiat Res
Li L, Sun X, Lin F, Zhang T, Zhou P, Liu Y.   +5 more
europepmc   +1 more source

Tumor marker-guided precision BNCT for CA19-9-positive cancers: a new paradigm in molecularly targeted chemoradiation therapy. [PDF]

J Transl Med
Kanehira N, Teraishi F, Tajima T, Osone T, Gotoh K, Fujimoto T, Sakurai Y, Kondo N, Nagahisa N, Kamei K, Fujita T, Morihara A, Takaguchi Y, Kitamatsu M, Takarada T, Shigeyasu K, Suzuki M, Fujiwara T, Michiue H.   +18 more
europepmc   +1 more source

Boron in Diet and Medicine: Mechanisms of Delivery and Detection. [PDF]

Pharmaceuticals (Basel)
Bartusik-Aebisher D, Rudy I, Rogóż K, Aebisher D, Henrykowska G.   +4 more
europepmc   +1 more source

LAT1 expression in head and neck cancer: a prognostic biomarker with potential relevance for BNCT. [PDF]

Front Oncol
Cavalieri S, Nuzzolese I, Lenoci D, Lucchetta M, Ficorilli M, Orlandi E, De Cecco L, Licitra L.   +7 more
europepmc   +1 more source

Boron neutron capture therapy in the context of tumor heterogeneity: progress, challenges, and future perspectives. [PDF]

Front Oncol
Zhou R, You Z, Liu L.
europepmc   +1 more source